Home » FDA Approves Roche’s Cytomegalovirus Test
FDA Approves Roche’s Cytomegalovirus Test
The FDA has approved Roche’s COBAS AmpliPrep/COBAS TaqMan cytomegalovirus test for use in hematopoietic stem cell transplant recipients.
Designed for use on the company’s COBAS AmpliPrep/COBAS TaqMan platform, the in vitro test is intended to facilitate the management of solid-organ transplant and hematopoietic stem-cell transplant recipients undergoing anti-CMV therapy.
The CMV test is the first to nab FDA approval for this indication, according to the company. — Anisa Jibrell
Upcoming Events
-
11Jul
-
18Jul
-
21Oct